Patel Dinesh V Ph D - Net Worth and Insider Trading
Patel Dinesh V Ph D Net Worth
The estimated net worth of Patel Dinesh V Ph D is at least $15 Million dollars as of 2025-01-15. Patel Dinesh V Ph D is the President and CEO of Protagonist Therapeutics Inc and owns about 408,455 shares of Protagonist Therapeutics Inc (PTGX) stock worth over $15 Million. Details can be seen in Patel Dinesh V Ph D's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Patel Dinesh V Ph D has not made any transactions after 2024-11-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Patel Dinesh V Ph D
Patel Dinesh V Ph D Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Patel Dinesh V Ph D owns 1 companies in total, including Protagonist Therapeutics Inc (PTGX) .
Click here to see the complete history of Patel Dinesh V Ph D’s form 4 insider trades.
Insider Ownership Summary of Patel Dinesh V Ph D
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PTGX | Protagonist Therapeutics Inc | 2024-11-26 | director & President and CEO |
Patel Dinesh V Ph D Latest Holdings Summary
Patel Dinesh V Ph D currently owns a total of 1 stock. Patel Dinesh V Ph D owns 408,455 shares of Protagonist Therapeutics Inc (PTGX) as of November 26, 2024, with a value of $15 Million.
Latest Holdings of Patel Dinesh V Ph D
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PTGX | Protagonist Therapeutics Inc | 2024-11-26 | 408,455 | 36.67 | 14,978,045 |
Holding Weightings of Patel Dinesh V Ph D
Patel Dinesh V Ph D Form 4 Trading Tracker
According to the SEC Form 4 filings, Patel Dinesh V Ph D has made a total of 7 transactions in Protagonist Therapeutics Inc (PTGX) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Protagonist Therapeutics Inc is the sale of 100,000 shares on November 26, 2024, which brought Patel Dinesh V Ph D around $5 Million.
Insider Trading History of Patel Dinesh V Ph D
- 1
Patel Dinesh V Ph D Trading Performance
GuruFocus tracks the stock performance after each of Patel Dinesh V Ph D's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Patel Dinesh V Ph D is 70.15%. GuruFocus also compares Patel Dinesh V Ph D's trading performance to market benchmark return within the same time period. The performance of stocks bought by Patel Dinesh V Ph D within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Patel Dinesh V Ph D's insider trading performs compared to the benchmark.
Performance of Patel Dinesh V Ph D
Patel Dinesh V Ph D Ownership Network
Ownership Network List of Patel Dinesh V Ph D
Ownership Network Relation of Patel Dinesh V Ph D
Patel Dinesh V Ph D Owned Company Details
What does Protagonist Therapeutics Inc do?
Who are the key executives at Protagonist Therapeutics Inc?
Patel Dinesh V Ph D is the director & President and CEO of Protagonist Therapeutics Inc. Other key executives at Protagonist Therapeutics Inc include Chief Medical Officer Arturo Md Molina , Chief Development Officer Suneel Gupta , and Chief Financial Officer Asif Ali .
Protagonist Therapeutics Inc (PTGX) Insider Trades Summary
Over the past 18 months, Patel Dinesh V Ph D made 5 insider transaction in Protagonist Therapeutics Inc (PTGX) with a net sale of 265,000. Other recent insider transactions involving Protagonist Therapeutics Inc (PTGX) include a net sale of 36,975 shares made by William D. Waddill , a net sale of 39,624 shares made by Asif Ali , and a net sale of 35,283 shares made by Arturo Md Molina .
In summary, during the past 3 months, insiders sold 256,063 shares of Protagonist Therapeutics Inc (PTGX) in total and bought 0 shares, with a net sale of 256,063 shares. During the past 18 months, 504,510 shares of Protagonist Therapeutics Inc (PTGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 504,510 shares.
Protagonist Therapeutics Inc (PTGX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protagonist Therapeutics Inc Insider Transactions
Patel Dinesh V Ph D Mailing Address
Above is the net worth, insider trading, and ownership report for Patel Dinesh V Ph D. You might contact Patel Dinesh V Ph D via mailing address: C/o Protagonist Therapeutics, Inc., 521 Cottonwood Drive, Suite 100, Milpitas Ca 95035.